Evidence map›Paper›PMID 32169845›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Leukemia Inhibitory Factor Inhibits Plasmacytoid Dendritic Cell Function and Development.

Renata Sesti-Costa, Luisa Cervantes-Barragan, Melissa K Swiecki, José Luís Fachi, Marina Cella, Susan Gilfillan, João Santana Silva, Marco Colonna

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Renata Sesti-CostaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.ORCID 0000-0002-7098-2850
Luisa Cervantes-BarraganDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.
Melissa K SwieckiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.
José Luís FachiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.ORCID 0000-0002-1035-5193
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.ORCID 0000-0003-1230-1313
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and.ORCID 0000-0003-1672-0996
João Santana SilvaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil 14049-900.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and mcolonna@wustl.edu.
Washington University in St. Louis · USUniversidade de Ribeirão Preto · BR

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTESR01DK103039 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2015 to 2018
$1.4M
NCI NIH HHS P30 CA091842NIDDK NIH HHS R01 DK103039
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) produce abundant type I IFNs (IFN-I) in response to viral nucleic acids. Generation of pDCs from bone marrow dendritic cell (DC) progenitors and their maintenance is driven by the transcription factor E2-2 and inhibited by its repressor Id2. In this study, we find that mouse pDCs selectively express the receptor for LIF that signals through STAT3. Stimulation of pDCs with LIF inhibited IFN-I, TNF, and IL-6 responses to CpG and induced expression of the STAT3 targets SOCS3 and Bcl3, which inhibit IFN-I and NF-κB signaling. Moreover, although STAT3 has been also reported to induce E2-2, LIF paradoxically induced its repressor Id2. A late-stage bone marrow DC progenitor expressed low amounts of LIFR and developed into pDCs less efficiently after being exposed to LIF, consistent with the induction of Id2. Conversely, pDC development and serum IFN-I responses to lymphocytic choriomeningitis virus infection were augmented in newly generated mice lacking LIFR in either CD11c

Indexed as

AnimalsDendritic CellsInterferon Type ILeukemia Inhibitory FactorMiceMice, Inbred C57BLMice, TransgenicSignal TransductionSTAT3 Transcription FactorInterferon Type ILeukemia Inhibitory FactorLif protein, mouseStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID32169845
PMCPMC7453765
OpenAlexW3011974191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.